Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized herpes zoster virus mRNA vaccine Phase I/II trial in adults ≥40 years
CTR20254939Phase 2Active
- Sponsor
- Sino Biopharmaceutical Limited
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of lyophilized herpes zoster mRNA vaccine in herpes zoster (HZ), sponsored by Sino Biopharmaceutical Limited. Started Dec 2025; status: active.
02
Drugs
lyophilized herpes zoster mRNA vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20254939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254939.